患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

ENGLISH
国立保健医療科学院
クリップした情報
×

情報をクリップできます

治験情報をこちらのホームページで一時的にクリップすることが出来ます。

削除
治験例

海外の治験の状況「前立腺癌」での検索結果

絞り込み

107件の検索結果
  • 進捗状況
  • 試験名
  • 対象疾患名
  • 国名
  • 登録日
  •  

  • Not Recruiting

  • Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-refractory Prostate Cancer
  • Metastatic castrate-resistant prostate cancer br>MedDRA version: 14.0 Level: LLT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
  • Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Costa Rica, Czech Republic, Denmark, Estonia, European Union, Finland, Germany, Greece, Hungary, India, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Panama, Peru, Russian Federation, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
  • 2006-03-31

  • Not recruiting

  • Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer
  • Hormone Refractory Prostate Cancer;Hormone Refractory Prostate Cancer;Hormone Refractory Prostate Cancer;Hormone Refractory Prostate Cancer
  • Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czech Republic, Finland, Former Serbia and Montenegro, France, Germany, Hungary, India, Ireland, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
  • 2006-02-02

  • Not recruiting

  • Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
  • Febrile Neutropenia;Cancer;Breast Cancer;Ovarian Cancer;Lung Cancer;Prostate Cancer;Multiple Myeloma;Bladder Cancer;B-cell Lymphoma;Febrile Neutropenia;Cancer;Breast Cancer;Ovarian Cancer;Lung Cancer;Prostate Cancer;Multiple Myeloma;Bladder Cancer;B-cell Lymphoma;Febrile Neutropenia;Cancer;Breast Cancer;Ovarian Cancer;Lung Cancer;Prostate Cancer;Multiple Myeloma;Bladder Cancer;B-cell Lymphoma;Febrile Neutropenia;Cancer;Breast Cancer;Ovarian Cancer;Lung Cancer;Prostate Cancer;Multiple Myeloma;Bladder Cancer;B-cell Lymphoma
  • Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, Spain, Switzerland, United Kingdom
  • 2011-08-30

  • Not Recruiting

  • Sipuleucel-T Manufacturing Demonstration Study
  • metastatic castrate resistant prostate cancer br>MedDRA version: 14.1 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: LLT Classification code 10036910 Term: Prostate cancer NOS System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: LLT Classification code 10066489 Term: Progression of prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
  • Austria, Netherlands, United Kingdom
  • 2011-11-17

  • Not recruiting

  • Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
  • Anemia;Breast Cancer;Cancer;Colorectal Cancer;Lung Cancer;Ovarian Cancer;Prostate Cancer;Solid Tumors;Bladder Cancer;Endometrial Cancer;Renal Cancer;Pancreatic Cancer;Esophageal Cancer;Gastric Cancer;Anemia;Breast Cancer;Cancer;Colorectal Cancer;Lung Cancer;Ovarian Cancer;Prostate Cancer;Solid Tumors;Bladder Cancer;Endometrial Cancer;Renal Cancer;Pancreatic Cancer;Esophageal Cancer;Gastric Cancer;Anemia;Breast Cancer;Cancer;Colorectal Cancer;Lung Cancer;Ovarian Cancer;Prostate Cancer;Solid Tumors;Bladder Cancer;Endometrial Cancer;Renal Cancer;Pancreatic Cancer;Esophageal Cancer;Gastric Cancer;Anemia;Breast Cancer;Cancer;Colorectal Cancer;Lung Cancer;Ovarian Cancer;Prostate Cancer;Solid Tumors;Bladder Cancer;Endometrial Cancer;Renal Cancer;Pancreatic Cancer;Esophageal Cancer;Gastric Cancer
  • Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Romania
  • 2011-09-29

  • Not recruiting

  • Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer
  • Bone Metastases in Men With Hormone-Refractory Prostate Cancer;Bone Metastases in Subjects With Advanced Breast Cancer;Bone Metastases in Men With Hormone-Refractory Prostate Cancer;Bone Metastases in Subjects With Advanced Breast Cancer
  • Argentina, Austria, Belgium, Brazil, Czech Republic, Czechia, France, Hungary, India, Israel, Italy, Japan, Latvia, Lithuania, Panama, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
  • 2011-08-04

  • Not recruiting

  • A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
  • Benign Prostatic Hyperplasia (BPH);Benign Prostatic Hyperplasia (BPH);Benign Prostatic Hyperplasia (BPH);Benign Prostatic Hyperplasia (BPH)
  • Australia, Austria, Belgium, France, Germany, Greece, Italy, Mexico, Netherlands, Poland
  • 2009-09-01